PT3399962T - Composição oftálmica para o tratamento da doença do olho seco - Google Patents

Composição oftálmica para o tratamento da doença do olho seco

Info

Publication number
PT3399962T
PT3399962T PT178320669T PT17832066T PT3399962T PT 3399962 T PT3399962 T PT 3399962T PT 178320669 T PT178320669 T PT 178320669T PT 17832066 T PT17832066 T PT 17832066T PT 3399962 T PT3399962 T PT 3399962T
Authority
PT
Portugal
Prior art keywords
treatment
dry eye
ophthalmic composition
eye disease
ophthalmic
Prior art date
Application number
PT178320669T
Other languages
English (en)
Original Assignee
Novaliq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh
Publication of PT3399962T publication Critical patent/PT3399962T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • A61J1/067Flexible ampoules, the contents of which are expelled by squeezing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PT178320669T 2016-12-23 2017-12-20 Composição oftálmica para o tratamento da doença do olho seco PT3399962T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16206735 2016-12-23
EP17165578 2017-04-07

Publications (1)

Publication Number Publication Date
PT3399962T true PT3399962T (pt) 2020-09-03

Family

ID=61002978

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178320669T PT3399962T (pt) 2016-12-23 2017-12-20 Composição oftálmica para o tratamento da doença do olho seco

Country Status (14)

Country Link
US (2) US20180360908A1 (pt)
EP (3) EP3777830B1 (pt)
JP (2) JP7032404B2 (pt)
KR (1) KR102288022B1 (pt)
CN (1) CN110267645A (pt)
AU (1) AU2017384650B2 (pt)
BR (1) BR112019012791A2 (pt)
CA (1) CA3045743C (pt)
DK (1) DK3399962T3 (pt)
ES (2) ES2965883T3 (pt)
MX (1) MX2019007587A (pt)
PL (1) PL3399962T3 (pt)
PT (1) PT3399962T (pt)
WO (1) WO2018115097A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2547323T3 (en) 2010-03-17 2016-05-02 Novaliq Gmbh PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INCREASED INTRAOCULAR PRESSURE
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
ES2621226T3 (es) 2012-09-12 2017-07-03 Novaliq Gmbh Composiciones de alcanos semifluorados
EP3100722B1 (en) 2012-09-12 2024-03-20 Novaliq GmbH Semifluorinated alkanes for use in solubilizing meibum
WO2015011199A1 (en) 2013-07-23 2015-01-29 Novaliq Gmbh Stabilized antibody compositions
ES2743502T3 (es) 2015-09-30 2020-02-19 Novaliq Gmbh Compuestos semifluorados y sus composiciones
US11154513B2 (en) 2015-09-30 2021-10-26 Novaliq Gmbh Semifluorinated compounds
PT3442480T (pt) 2016-06-23 2019-12-23 Novaliq Gmbh Método de administração tópica
CA3036297C (en) 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
KR20190057338A (ko) 2016-09-23 2019-05-28 노바리크 게엠베하 시클로스포린을 포함하는 안과 조성물
ES2957559T3 (es) 2017-04-21 2024-01-22 Dermaliq Therapeutics Inc Composiciones de yodo
EP3621601A1 (en) 2017-05-12 2020-03-18 Novaliq GmbH Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
IL273531B2 (en) 2017-09-27 2024-05-01 Novaliq Gmbh Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
EP3758676A1 (en) 2018-03-02 2021-01-06 Novaliq GmbH Pharmaceutical compositions comprising nebivolol
SG11202102820VA (en) * 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
CA3141386A1 (en) * 2019-05-24 2020-12-03 Novaliq Gmbh Ophthalmic composition for the treatment of ocular allergy
EP3861857A1 (en) * 2020-02-07 2021-08-11 Novaliq GmbH Antiparasitic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
WO2013126602A1 (en) * 2012-02-21 2013-08-29 Massachusetts Eye & Ear Infirmary Inflammatory eye disorders
US9878000B2 (en) * 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
EP3100722B1 (en) * 2012-09-12 2024-03-20 Novaliq GmbH Semifluorinated alkanes for use in solubilizing meibum
EP2935589A1 (en) * 2012-12-18 2015-10-28 Novartis AG Compositions and methods that utilize a peptide tag that binds to hyaluronan
EP3179975A4 (en) * 2014-08-13 2018-04-18 University of Florida Research Foundation, Inc. Preservative removal from eye drops

Also Published As

Publication number Publication date
KR102288022B1 (ko) 2021-08-10
JP2022050514A (ja) 2022-03-30
WO2018115097A1 (en) 2018-06-28
ES2965883T3 (es) 2024-04-17
AU2017384650B2 (en) 2021-02-18
ES2819005T3 (es) 2021-04-14
PL3399962T3 (pl) 2021-02-08
JP7032404B2 (ja) 2022-03-08
US20230043641A1 (en) 2023-02-09
BR112019012791A2 (pt) 2019-12-03
EP3777830A1 (en) 2021-02-17
DK3399962T3 (da) 2020-09-07
WO2018115097A9 (en) 2018-08-23
EP3777830B1 (en) 2023-11-29
EP3777830C0 (en) 2023-11-29
JP2020502197A (ja) 2020-01-23
KR20190100283A (ko) 2019-08-28
CA3045743C (en) 2023-08-29
EP3399962B1 (en) 2020-06-10
EP3399962A1 (en) 2018-11-14
AU2017384650A1 (en) 2019-07-04
CN110267645A (zh) 2019-09-20
US20180360908A1 (en) 2018-12-20
EP4374851A2 (en) 2024-05-29
MX2019007587A (es) 2019-12-16
CA3045743A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
PL3399962T3 (pl) Kompozycja okulistyczna do leczenia choroby suchego oka
HK1258588A1 (zh) 用於治療眼科疾病的化合物和製劑
HK1231417A1 (zh) 用於治療眼科疾病和障礙的化合物
EP3390634A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
IL246791A0 (en) Compositions and methods for treating eye diseases
IL281773A (en) Eye preparation for the treatment of dry eye disease
EP3261620A4 (en) Methods and compositions for treating dry eye disease and other eye disorders
EP3351219A4 (en) MATERIAL FOR THE OPTICAL TREATMENT OF OCULAR DISEASES
PL3419622T3 (pl) Leczenie neurodegeneracyjnej choroby oczu przy użyciu pridopidyny
SI3210973T1 (sl) Heteroarilne spojine za zdravljenje oftalmičnih bolezni
IL267229A (en) Methods of treating ocular disorders
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
IL269698B (en) Methods for preventing or treating eye diseases
IL259381B (en) Miravegron for the treatment of retinal diseases
PL3689341T3 (pl) Gabapentyna okulistyczna do leczenia deepitelializacji rogówki
PL3229780T3 (pl) Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka
GB201910645D0 (en) Treatment for dry eye disease
SG11202005278PA (en) Compounds for treating eye diseases and methods thereof
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
IL263837A (en) Treatment of ocular disease
ZA201906465B (en) Compositions and methods for treating dry eye diseases
GB201610938D0 (en) Treatment of ocular disease
GB201705435D0 (en) Treatment of ocular disease
AU2016905281A0 (en) Pharmaceutical composition for treatment of an eye disease or condition
AU2016904360A0 (en) Pharmaceutical composition for treatment of an eye disease or condition